Literature DB >> 12356094

International Conference on Harmonisation; guidance on specifications: test procedures and acceptance criteria for biotechnological/biological products. Notice. Food and Drug Administration, HHS.

.   

Abstract

The Food and Drug Administration (FDA) is publishing a guidance entitled "Q6B Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products." The guidance was prepared under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The guidance provides guidance on general principles for the selection of test procedures and the setting and justification of acceptance criteria for biotechnological and biological products. The guidance is intended to assist in the establishment of a uniform set of international specifications for biotechnological and biological products to support new marketing applications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 12356094

Source DB:  PubMed          Journal:  Fed Regist        ISSN: 0097-6326


  12 in total

Review 1.  Progress in the use of biological assays during the development of biotechnology products.

Authors:  A R Mire-Sluis
Journal:  Pharm Res       Date:  2001-09       Impact factor: 4.200

2.  PCDDB: the Protein Circular Dichroism Data Bank, a repository for circular dichroism spectral and metadata.

Authors:  Lee Whitmore; Benjamin Woollett; Andrew John Miles; D P Klose; Robert W Janes; B A Wallace
Journal:  Nucleic Acids Res       Date:  2010-11-11       Impact factor: 16.971

3.  Engineering a therapeutic IgG molecule to address cysteinylation, aggregation and enhance thermal stability and expression.

Authors:  Andrew Buchanan; Veronica Clementel; Rob Woods; Nicholas Harn; Michael A Bowen; Wenjun Mo; Bojana Popovic; Steven M Bishop; William Dall'Acqua; Ralph Minter; Lutz Jermutus; Vahe Bedian
Journal:  MAbs       Date:  2013-02-14       Impact factor: 5.857

4.  Development of orthogonal NISTmAb size heterogeneity control methods.

Authors:  Abigail Turner; Katharina Yandrofski; Srivalli Telikepalli; Jason King; Alan Heckert; James Filliben; Dean Ripple; John E Schiel
Journal:  Anal Bioanal Chem       Date:  2018-02-10       Impact factor: 4.142

5.  A reporter gene assay for determining the biological activity of therapeutic antibodies targeting TIGIT.

Authors:  Zhihao Fu; Hongchuan Liu; Lan Wang; Chuanfei Yu; Yalan Yang; Meiqing Feng; Junzhi Wang
Journal:  Acta Pharm Sin B       Date:  2021-09-17       Impact factor: 11.413

6.  Preclinical Evaluation of the Safety and Efficacy of Cryopreserved Bone Marrow Mesenchymal Stromal Cells for Corneal Repair.

Authors:  Ilham Putra; Xiang Shen; Khandaker N Anwar; Behnam Rabiee; Ravand Samaeekia; Enmar Almazyad; Pushpanjali Giri; Sayena Jabbehdari; Mohammed R Hayat; Abdelrahman M Elhusseiny; Mahmood Ghassemi; Nadim Mahmud; Deepak P Edward; Charlotte E Joslin; Mark I Rosenblatt; Reza Dana; Medi Eslani; Peiman Hematti; Ali R Djalilian
Journal:  Transl Vis Sci Technol       Date:  2021-08-12       Impact factor: 3.283

7.  Consistency of quality attributes for the glycosylated monoclonal antibody Humira® (adalimumab).

Authors:  Paul W Tebbey; Amy Varga; Michael Naill; Jerry Clewell; Jaap Venema
Journal:  MAbs       Date:  2015       Impact factor: 5.857

8.  Advanced assessment of the physicochemical characteristics of Remicade® and Inflectra® by sensitive LC/MS techniques.

Authors:  Jing Fang; Catalin Doneanu; William R Alley; Ying Qing Yu; Alain Beck; Weibin Chen
Journal:  MAbs       Date:  2016-06-03       Impact factor: 5.857

9.  Clinical Implementation of Pharmacogenetic Testing in a Hospital of the Spanish National Health System: Strategy and Experience Over 3 Years.

Authors:  Alberto M Borobia; Irene Dapia; Hoi Y Tong; Pedro Arias; Mario Muñoz; Jair Tenorio; Rafael Hernández; Irene García García; Gema Gordo; Elena Ramírez; Jesús Frías; Pablo Lapunzina; Antonio J Carcas
Journal:  Clin Transl Sci       Date:  2017-11-28       Impact factor: 4.689

10.  Synthesis, LC-MS/MS analysis, and biological evaluation of two vaccine candidates against ticks based on the antigenic P0 peptide from R. sanguineus linked to the p64K carrier protein from Neisseria meningitidis.

Authors:  Luis Javier González; Pedro E Encinosa Guzmán; Wendy Machado; Satomy Pousa; Alejandro Leyva; Ana Laura Cano Arguelles; Gleysin Cabrera; Luis Ariel Espinosa; Rubén Parra; Rachel Hernández; Yamil Bello Soto; Frank L Ledesma; Marisdania Joglar; Osmany Guirola; Louise Ulrich Kurt; Paulo C Carvalho; Ania Cabrales; Hilda Garay; Vladimir Besada; Rosario Durán; Toshifumi Takao; Mario Pablo Estrada; Alina Rodríguez-Mallon
Journal:  Anal Bioanal Chem       Date:  2021-08-03       Impact factor: 4.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.